SCHEMBL1668167

SCHEMBL1668167

O=CCc1ccc(Nc2cccc(Br)c2)c([N+](=O)[O-])c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
HCAR3 P49019 1/20 0.43
WNK1 Q9H4A3 1/20 0.43
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
POLB P06746 1/20 0.42
AKR1B1 P15121 2/20 0.41
AKR1C4 P17516 2/20 0.41
AKR1C3 P42330 2/20 0.41
AKR1C2 P52895 2/20 0.41
AKR1C1 Q04828 2/20 0.41
AKR1B10 O60218 1/20 0.41
HPGD P15428 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP7 P55210 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH3A1 P30838 1/20 0.41
FBP1 P09467 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2652766 0.86 HCAR3 (0.47) EGFRL3MBTL1HCAR3WNK1MAPT
SCHEMBL15984934 0.84 EGFR (0.55) EGFRL3MBTL1HCAR3WNK1MAPT
SCHEMBL12415846 0.79 EGFR (0.51) EGFRL3MBTL1HCAR3WNK1MAPT
SCHEMBL4063056 0.78 TDP1 (0.68) EGFRL3MBTL1HCAR3WNK1MAPT
SCHEMBL27697296 0.77 ALDH3A1 (0.46) EGFRL3MBTL1HCAR3WNK1MAPT
SCHEMBL2338144 0.76 HCAR3 (0.76) HCAR3MAPTPOLBAKR1B1AKR1C4
SCHEMBL1668098 0.76 AKR1B1 (0.53) EGFRL3MBTL1HCAR3WNK1MAPT
SCHEMBL1668253 0.76 AKR1B1 (0.69) EGFRL3MBTL1WNK1MAPTAKR1B1
SCHEMBL12591638 0.76 EGFR (0.46) EGFRL3MBTL1HCAR3WNK1MAPT
SCHEMBL2648562 0.76 HCAR3 (0.76) HCAR3MAPTPOLBAKR1B1AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011047315-A1 SUBSITITUTED BENZIMIDAZOLES CONCERT PHARMACEUTICALS, INC. (US) 2011-04-21 WO disclosed